Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Proterra Wins $26.5M Transit Bus Order From Pace Suburban Bus

Pace Suburban Bus has awarded Proterra Inc (NASDAQ:PTRA) a $26.5 million contract to acquire 20 Proterra ZX5 Max electric transit buses. Pace…
byShivani Kumaresan
April 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Pace Suburban Bus has awarded Proterra Inc (NASDAQ:PTRA) a $26.5 million contract to acquire 20 Proterra ZX5 Max electric transit buses. Pace is a public bus service operator in North America.
  • The 40-foot Proterra ZX5 Max features 675-kilowatt hours (kWh) of energy storage. The contract also includes two Proterra megawatt-scale fleet chargers.
  • The procurement is Pace’s first order of battery-electric buses as the agency seeks to transition to a zero-emission fleet by 2040.
  • The company expects to deliver the first Proterra electric buses to Pace in 2023.
  • Price Action: PTRA shares are trading lower by 4.24% at $7.46 on the last check Tuesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sangamo Therapeutics Announced Updated Preliminary SAR445136 Phase 1/2 Proof-of-Concept Data Showing Tolerability and Sustained Effects in Sickle Cell Disease at ASH 2021; Said All Four Treated Patients Experienced Increases In Total Hemoglobin, Fetal…

By Charles Gross
Today, 3:19 AM
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced updated preliminary proof-of-concept clinical data from the Phase 1/2 PRECIZN-1 study of SAR445136, a zinc finger nuclease gene-edited cell therapy candidate in development with Sanofi for the treatment of sickle cell disease (SCD).

SGMO